Btc.Ax
BTC.AX operates in the healthcare diagnostics sector, providing diagnostic services and related healthcare solutions.
Business. BTC.AX operates in the healthcare diagnostics sector, providing diagnostic services and related healthcare solutions.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BTC.AX operates in the healthcare diagnostics sector, providing diagnostic services and related healthcare solutions.
BTC.AX maintains a strong liquidity position with a current ratio of 3.16, indicating the company can easily cover its short-term liabilities with its current assets. The company has no long-term debt and holds $620,110 in cash and equivalents, further supporting its liquidity profile. Despite a negative operating cash flow of -$499,980, the company's free cash flow is positive at $3,981,300, suggesting it can fund operations and potentially invest in growth.
In terms of profitability, BTC.AX demonstrates a high return on equity (ROE) of 43.48% and a return on assets (ROA) of 42.54%, both significantly above the industry median for healthcare diagnostics. These metrics indicate efficient use of equity and assets to generate profits, which is a positive sign for investors.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification reported. This concentration may expose the company to higher risks if the segment faces challenges or if the local market experiences downturns.
Looking at the growth trajectory, BTC.AX reported revenue of $9,960 in the latest period. While the company is profitable with a net income of $3,981,300, the operating income is negative at -$665,520, indicating that operational costs are currently exceeding revenue. The outlook for the next fiscal year is not explicitly provided, but the company's strong free cash flow suggests it has the financial flexibility to support growth initiatives.
The risk assessment for BTC.AX indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company has no long-term debt and a low debt-to-equity ratio of 0.0, which reduces financial leverage risk. The dilution potential is also low, with no significant dilution sources identified in the latest filings.
Recent events and filings for BTC.AX do not show any material changes or significant risks that would impact the company's operations or financial health. The company's financial statements and disclosures are consistent with a stable and profitable business model.
- BTC.AX has a strong liquidity position with a current ratio of 3.16 and no long-term debt.
- The company demonstrates high profitability with a return on equity of 43.48% and a return on assets of 42.54%.
- BTC.AX's revenue is concentrated in a single business segment, which may increase operational risk.
- The company has a positive free cash flow of $3,981,300, indicating financial flexibility for growth.
- BTC.AX has low liquidity and dilution risks, with no immediate filing-based flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- BTC.AX Market data — financials · 2026-05-27
Ownership & reference
Leadership
- Richard S. TreagusExecutive Chairman of the Board
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total assets (YoY) (2025-12-31 vs 2024-12-31): 19.5%Derived (calculated)
- Return on assets (FY 2025-12-31): -10.3%Derived (calculated)
- Total liabilities (annual): USD 0SEC XBRL filing
- Net income (annual): USD -437.22MSEC XBRL filing
- Operating cash flow (annual): USD -1.12BSEC XBRL filing
- Total assets (annual): USD 4.24BSEC XBRL filing
- Total assets (annual): USD 3.55BSEC XBRL filing